$$$ SCOPE
- $30B+ managed through Provista contracts
- 5.2% price advantage over other pharmacy programs
- $50M+ in failure-to-supply program reimbursements since 2008
PROGRAM DETAILS
- 127,565+ participating healthcare facilities
- 12,000+ contracted products, including generics, brand, biosimilars, plasma and radiopharmaceuticals
NOVAPLUS
- 800+ drugs, including shortage-prone generic injectables
- 100 critical-access medicines
- 21% savings on purchases
PLASMA
- 22% of the nation's plasma under contract
- 2nd largest plasma program in the nation (behind the U.S.
VALUE-ADDS
- Manage drug spend
- Access essential drugs
- Improve patient outcomes
- Ensure regulatory compliance
- Improve clinical and operations insights
- Drive organizational performance
BY THE NUMBERS*
- $310M per year, financial impact of “white bagging”
- $345M per year cost of labor needed to manage drug shortages
- $470M inventory cost avoidance through Novaplus Enhanced Supply
*Numbers include acute care facilities
